{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:22:04Z","timestamp":1788092524951,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,2,1]],"date-time":"1990-02-01T00:00:00Z","timestamp":633830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1990,2,1]],"date-time":"1990-02-01T00:00:00Z","timestamp":633830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1990,2]]},"DOI":"10.1007\/bf00216936","type":"journal-article","created":{"date-parts":[[2004,9,25]],"date-time":"2004-09-25T19:53:13Z","timestamp":1096141993000},"page":"113-119","source":"Crossref","is-referenced-by-count":66,"title":["Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas"],"prefix":"10.1007","volume":"8","author":[{"given":"Robert H.","family":"Earhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Yuang-Chi Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest C.","family":"Borden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Comis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF00216936_CR1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000658-198704000-00003","volume":"205","author":"W Lawrence Jr","year":"1987","unstructured":"Lawrence Jr W, Donegan WL, Natarajan N, Mettlin C, Beart R, Winchester D: Adult Soft Tissue Sarcomas. Ann Surg 205:349\u2013359, 1987","journal-title":"Ann Surg"},{"key":"BF00216936_CR2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archsurg.1983.01390080023007","volume":"118","author":"MP Vezeridis","year":"1983","unstructured":"Vezeridis MP, Moore R, Karakousis CP: Metastatic Patterns in Soft-Tissue Sarcomas. Arch Surg 118:915\u2013918, 1983","journal-title":"Arch Surg"},{"key":"BF00216936_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1200\/JCO.1985.3.3.353","volume":"3","author":"DA Potter","year":"1985","unstructured":"Potter DA, Glenn J, Kinsella T, Glatstein E, Lack EE, Restrepo C, White DE, Seipp CA, Wesley R, Rosenberg SA: Patterns of Recurrence in Patients With High-Grade SoftTissue Sarcomas. J Clin Oncol 3:353\u2013366, 1985","journal-title":"J Clin Oncol"},{"key":"BF00216936_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1200\/JCO.1987.5.1.21","volume":"5","author":"F Eilber","year":"1987","unstructured":"Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J: Adjuvant Chemotherapy for Osteosarcoma: A Randomized Prospective Trial. J Clin Oncol 5:21\u201326, 1987","journal-title":"J Clin Oncol"},{"key":"BF00216936_CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/1097-0142(19830801)52:3<424::AID-CNCR2820520307>3.0.CO;2-8","volume":"52","author":"SA Rosenberg","year":"1983","unstructured":"Rosenberg SA, Tepper J, Glatstein E, Costa J, Young R, Baker A, Brennan MF, Demoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R: Prospective Randomized Evaluation of Adjuvant Chemotherapy in Adults with Soft Tissue Sarcomas of the Extremities. Cancer 52:424\u2013434, 1983","journal-title":"Cancer"},{"key":"BF00216936_CR6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1200\/JCO.1986.4.4.552","volume":"4","author":"F Gherlinzoni","year":"1986","unstructured":"Gherlinzoni F, Bacci G, Picci P, Capanna R, Calderoni R, Lorenzi EG, Bernini M, Emiliani E, Barbieri E, Normand A, Campanacci M: A Randomized Trial for the Treatment of High-Grade Soft-Tissue Sarcomas of the Extremities: Preliminary Observations. J Clin Oncol 4:552\u2013558, 1986","journal-title":"J Clin Oncol"},{"key":"BF00216936_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0305-7372(77)80006-6","volume":"4","author":"HM Pinedo","year":"1977","unstructured":"Pinedo HM, Kenis Y: Chemotherapy of advanced softtissue sarcomas in adults. Cancer Treat Rev 4:67\u201386, 1977","journal-title":"Cancer Treat Rev"},{"key":"BF00216936_CR8","first-page":"193","volume":"162","author":"MJ Greenall","year":"1986","unstructured":"Greenall MJ, Magill GB, DeCosse JJ, Brennan MF: Chemotherapy for Soft Tissue Sarcoma. Surg Gyn Obstet 162:193\u2013198, 1986","journal-title":"Surg Gyn Obstet"},{"key":"BF00216936_CR9","first-page":"1033","volume":"63","author":"R Catane","year":"1979","unstructured":"Catane R, Von Hoff DD, Glaubiger DL, Muggia FM: Azaserine, DON, and Azotomycin: Three Diazo Analogs of 1-Glutamine with Clinical Antitumor Activity. Cancer Treat Rep 63:1033\u20131038, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR10","first-page":"47","volume":"55","author":"RF Pittillo","year":"1971","unstructured":"Pittillo RF, Woolley C, Brockman RW, Ho DH: Azotomycin (NSC-56654): biologic fate in mice and man. Cancer Chemother Rep 55:47\u201352, 1971","journal-title":"Cancer Chemother Rep"},{"key":"BF00216936_CR11","first-page":"611","volume":"52","author":"AJ Weiss","year":"1968","unstructured":"Weiss AJ, Ramirez, G, Grage T, Strawitz J, Goldman L, Downing V: Phase II Study of Azotomycin (NSC 56654). Cancer Chemother Rep 52:611\u2013614, 1968","journal-title":"Cancer Chemother Rep"},{"key":"BF00216936_CR12","first-page":"1719","volume":"61","author":"P Chang","year":"1977","unstructured":"Chang P, Wiernik PH: Phase II Study of Azotomycin in Sarcomas. Cancer Treat Rep 61:1719\u20131720, 1977","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/1097-0142(195711\/12)10:6<1138::AID-CNCR2820100608>3.0.CO;2-K","volume":"10","author":"GB Magill","year":"1957","unstructured":"Magill GB, Myers WPL, Reilly HC, Putnam RC, Magill JW, Sykes MP, Escher GC, Karnofsky DA, Burchenal JH:Pharmacological and Initial Therapeutic Observations on 6-diazo-5-oxo-l-norleucine (DON) in Human Neoplastic Disease. Cancer 10:1138\u20131150, 1957","journal-title":"Cancer"},{"key":"BF00216936_CR14","first-page":"1247","volume":"64","author":"RB Sklaroff","year":"1980","unstructured":"Sklaroff RB, Casper ES, Magill GB, Young CW: Phase I Study of 6-diazo-5-oxo-l-norleucine (DON). Cancer Treat Rep 64:1247\u20131251, 1980","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR15","first-page":"1215","volume":"66","author":"RH Earhart","year":"1982","unstructured":"Earhart RH, Koeller JM, Davis HL: Phase I Trial of 6-Diazo-5-oxo-l-norleucine (DON) Administered by 5-Day Courses. Cancer Treat Rep 66:1215\u20131217, 1982","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR16","first-page":"290","volume":"14","author":"ST Crooke","year":"1978","unstructured":"Crooke ST, Duvernay VH, Galvan L, Prestayko AW: Structure-Activity Relationship of Anthracycline Relative to Effects on Macromolecular Synthesis. Mol Pharmacol 14:290\u2013298, 1978","journal-title":"Mol Pharmacol"},{"key":"BF00216936_CR17","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7164\/antibiotics.28.830","volume":"28","author":"T Oki","year":"1975","unstructured":"Oki T, Matsuzawa Y, Yoshimoto A, Numata K, Kitamura I, Hori S, Takamatsu A, Umezawa H, Ishizuka M, Naganawa H, Suda H, Hamada M, Takeuchi T: New Antitumor Antibiotics, Aclacinomycin A and B. J Antibiot 28:830\u2013834, 1975","journal-title":"J Antibiot"},{"key":"BF00216936_CR18","first-page":"75","volume-title":"Recent Results in Cancer Research","author":"H Majima","year":"1980","unstructured":"Majima H: Preliminary Clinical Study of Aclacinomycin A. In: Carter SK, et al (eds), Recent Results in Cancer Research, Springer, New York, 1980, pp 75\u201381"},{"key":"BF00216936_CR19","first-page":"931","volume":"63","author":"J Ogawa","year":"1979","unstructured":"Ogawa J, Inagaki J, Horikoshi N, Inoue K, Chinen T, Ueoka H, Nagura E: Clinical Study of Aclacinomycin A. Cancer Treat Rep 63:931\u2013934, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0021-9681(74)90015-0","volume":"27","author":"M Zelen","year":"1974","unstructured":"Zelen M: The randomization and stratification of patients to clinical trials. J Chronic Dis 27:365\u2013375, 1974","journal-title":"J Chronic Dis"},{"key":"BF00216936_CR21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00170765","volume":"3","author":"DA Amato","year":"1985","unstructured":"Amato DA, Borden EC, Shiraki M, Enterline HT, Rosenbaum C, Davis HL, Paul AR, Stevens CM, Lerner HJ: Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma. Invest New Drugs 3:397\u2013401, 1985","journal-title":"Invest New Drugs"},{"key":"BF00216936_CR22","first-page":"725","volume":"69","author":"M Bertrand","year":"1985","unstructured":"Bertrand M, Multhauf P, Bartolucci A, Ellison D, Gockerman J: Phase II Study of Aclarubicin in Previously Untreated Patients with Advanced Soft Tissue Sarcomas: A South-western Cancer Study Group Trial. Cancer Treat Rep 69:725\u2013726, 1985","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR23","first-page":"71","volume":"71","author":"S Marsoni","year":"1987","unstructured":"Marsoni S, Hoth D, Simon R, Leyland-Jones B, De Rosa M, Wittes RE: Clinical drug development: An analysis of phase II trials, 1970\u20131985. Cancer Treat Rep 71:71\u201380, 1987","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR24","first-page":"881","volume":"65","author":"JT Thigpen","year":"1981","unstructured":"Thigpen JT, Vaughn C, Stuckey WJ: Phase II Trial of Anguidine in Patients With Sarcomas Unresponsive to Prior Chemotherapy: A Southwest Oncology Group Study. Cancer Treat Rep 65:881\u2013882, 1981","journal-title":"Cancer Treat Rep"},{"key":"BF00216936_CR25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0277-5379(82)90029-3","volume":"18","author":"V Bramwell","year":"1982","unstructured":"Bramwell V, Van Oosterom A, Mouridsen HT, Cheix F, Somers R, Thomas D, Rozencweig M: N-(Phosphonacetyl)-1-aspartate (PALA) in Advanced Soft Tissue Sarcoma: a Phase II Trial of the EORTC Soft Tissue Sarcoma Group. Eur J Clin Oncol 18:81\u201384, 1982","journal-title":"Eur J Clin Oncol"},{"key":"BF00216936_CR26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0277-5379(83)90034-2","volume":"19","author":"VHC Bramwell","year":"1983","unstructured":"Bramwell VHC, Mouridsen HT, Mulder JH, Somers R, Van Oosterom AT, Santoro A, Thomas D, Sylvester R, Markham D: Carminomycin vs Adriamycin in Advanced Soft Tissue Sarcomas: an EORTC Randomized Phase II Study. Eur J Cancer Clin Oncol 19:1097\u20131104, 1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF00216936_CR27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0277-5379(85)90086-0","volume":"21","author":"R Somers","year":"1985","unstructured":"Somers R, Rouesse J, Van Oosterom A, Thomas D: Phase II Study of Elliptinium in Metastatic Soft Tissue Sarcoma. Eur J Cancer Clin Oncol 21:591\u2013593, 1985","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF00216936_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00000421-198708000-00017","volume":"10","author":"R Pazdur","year":"1987","unstructured":"Pazdur R, Samson MK, Baker LH: Fludarabine Phosphate: Phase II Evaluation in Advanced Soft-Tissue Sarcomas. Am J Clin Oncol 10:341\u2013343, 1987","journal-title":"Am J Clin Oncol"},{"key":"BF00216936_CR29","first-page":"69","volume":"11","author":"RC Stuart-Harris","year":"1983","unstructured":"Stuart-Harris RC, Harper PG, Parsons CA, Kaye SB, Mooney CA, Gowing NF, Wiltshaw E: High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma. Cancer Chemother Pharmacol 11:69\u201372, 1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF00216936_CR30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0277-5379(87)90075-7","volume":"23","author":"VHC Bramwell","year":"1987","unstructured":"Bramwell VHC, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylverter R, Van Oosterom A: Cyclophosphamide versus Ifosfamide: Final Report of a Randomized Phase II Trial in Adult Soft Tissue Sarcomas. Eur J Cancer Clin Oncol 23:311\u2013321, 1987","journal-title":"Eur J Cancer Clin Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00216936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00216936\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00216936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00216936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T13:22:13Z","timestamp":1678540933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00216936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,2]]}},"alternative-id":["BF00216936"],"URL":"https:\/\/doi.org\/10.1007\/bf00216936","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,2]]}}}